KF
OREX

Krilogy Financial’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Krilogy Financial’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50
Closed – – 889
2017
Q2 		$0 Hold
50
– – ﹤0.01% 824
2017
Q1 		$0 Hold
50
– – ﹤0.01% 738
2016
Q4 		$0 Hold
50
– – ﹤0.01% 793
2016
Q3 		$0 Buy
+50
New +$189 ﹤0.01% 815
2016
Q2 		– Sell
-50
Closed -$1K – 800
2016
Q1 		$1K Hold
50
– – ﹤0.01% 694
2015
Q4 		$1K Hold
50
– – ﹤0.01% 419
2015
Q3 		$1K Buy
+50
New +$1.71K ﹤0.01% 612

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Krilogy Financial's OREX Position: Q3 2017 in Review

Krilogy Financial sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2017, closing a stake of 50 shares.

Krilogy Financial first reported a position in OREX in Q3 2015 and held it in 7 quarters. The position peaked at $1K in Q1 2016. 42 funds tracked by Wall St. Rank hold OREX as of Q3 2017.

  • Krilogy Financial reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Krilogy Financial sold 50 Orexigen Therapeutics, Inc. shares in Q3 2017.
  • Krilogy Financial first reported a position in Orexigen Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
  • Krilogy Financial's Orexigen Therapeutics, Inc. position peaked at $1K in Q1 2016.
  • 42 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2017.

Based on Krilogy Financial's 13F filing for Q3 2017, filed 15 Nov 2017.